SCHEMBL28503636

SCHEMBL28503636

O=C(NBr)c1nccs1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8592828 0.81
SCHEMBL6970218 0.79
SCHEMBL148962 0.79
SCHEMBL455410 0.79
SCHEMBL27623450 0.76
SCHEMBL247631 0.76
SCHEMBL28027939 0.75 ALDH1A1 (0.67)
SCHEMBL175249 0.75 ALDH1A1 (0.67)
SCHEMBL19691137 0.75 ALDH1A1 (0.55)
SCHEMBL12124477 0.75 ALDH1A1 (0.55)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112079769-A Carboxamide compounds for the treatment of metabolic disorders 里格尔药品股份有限公司 2020-12-15 CN disclosed
CN-106928211-B Carboxamide compounds for the treatment of metabolic disorders 里格尔药品股份有限公司 2020-09-08 CN disclosed